Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Breast Cancer Female × Dexmedetomidine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 7 Brain Neoplasms 6 Breast Neoplasms 5 Neoplasms 4 Thyroid Neoplasms 3 Agnosia 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Pheochromocytoma 2 Lung Neoplasms 2 Liver Neoplasms 2 Dexmedetomidine 2 Chronic Pain 2 Supratentorial Neoplasms 1 Sleep Initiation and Maintenance Disorders 1 Sigmoid Neoplasms 1 Seizures 1 Prostatic Hyperplasia 1 Postoperative Nausea and Vomiting 1 Postoperative Analgesia 1 Pneumoperitoneum 1 Pancreatic Neoplasms 1 Pain, Intractable 1 Obesity 1 Neuroinflammatory Diseases 1 Neurofibromatoses 1 Neurocognitive Disorders 1 Neoplasm Metastasis 1

Interventions

Exercise 3 Paclitaxel 2 Cyclophosphamide 2 Capecitabine 2 Bupivacaine 2 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 palbociclib 1 iniparib 1 darolutamide 1 Yoga 1 Waiting Lists 1 Vitamin D 1 Thioctic Acid 1 Surveys and Questionnaires 1 Sodium Chloride 1 Ropivacaine 1 Radiofrequency Ablation 1 Neoadjuvant Therapy 1 Methotrexate 1 Metformin 1 Mastectomy 1 Electrochemotherapy 1 Educational Status 1 Drug Delivery Systems 1 Doxorubicin 1 Diet 1 Dexmedetomidine 1 Control Groups 1 Caloric Restriction 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03063073 2026-02-12

pec's

South Egypt Cancer Institute

Phase 3 Completed

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡